We are live on
!
Find out more
PVLA
Palvella Therapeutics
PVLA
PVLA
140 hedge funds and large institutions have $1.02B invested in Palvella Therapeutics in 2025 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 42 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
342% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 12
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
97% more call options, than puts
Call options by funds: $20.2M | Put options by funds: $10.2M
91% more capital invested
Capital invested by funds: $534M → $1.02B (+$487M)
45% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 29
40% more funds holding
Funds holding: 100 → 140 (+40)
5.37% more ownership
Funds ownership: 77.09% → 82.45% (+5.4%)
Holders
140
Holders Change
+40
Holders Change %
+40%
% of All Funds
1.7%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.05%
New
53
Increased
42
Reduced
29
Closed
12
Calls
$20.2M
Puts
$10.2M
Net Calls
+$9.97M
Net Calls Change
+$9.31M
Top Buyers
| 1 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$30.2M |
| 2 |
State Street
Boston,
Massachusetts
|
+$24.2M |
| 3 |
Jennison Associates
New York
|
+$23.9M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$22.9M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$18M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$24.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$20.5M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$15.7M |
| 4 |
Goldman Sachs
New York
|
-$11.7M |
| 5 |
PA
Perceptive Advisors
New York
|
-$11M |
